Premium
Current and future therapies for advanced pancreatic cancer
Author(s) -
Gupta Rohan,
Amanam Idoroenyi,
Chung Vincent
Publication year - 2017
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.24623
Subject(s) - medicine , pancreatic cancer , cancer , chemotherapy , oncology , disease , overall survival , surgical resection , surgery , general surgery
Pancreatic cancer remains a deadly disease with a 5‐year survival rate of only 8%. Even after surgical resection, most patients have recurrence of their cancer. Over the last 10 years, improvements in chemotherapy regimens led to a doubling in median overall survival. Here we review the management of advanced pancreatic cancer and highlight vaccine therapy as a novel modality of treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom